drugset / Trial / NCT01224834

Safety and Tolerability Study of Ragweed SLIT Tablets

NCT01224834 ↗

Phase 1 Completed 60 enrolled Stallergenes Greer Quintiles, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and tolerability of several doses of ragweed pollen allergen extract administered as sublingual tablets in subjects with allergic rhinitis to ragweed.

Timeline

Start
2009-01
Primary completion
2009-04
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ragweed pollen allergen extract Unknown — Other